5F-MDMB-PICA

Synthetic cannabinoid
{{Drugbox | verifiedrevid = 477318464 | IUPAC_name = Methyl 2-[[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino]-3,3-dimethylbutanoate | image = 5F-MDMB-PICA_structure.png | width = 200 | legal_uk = Class B | legal_us = Schedule I | legal_ca = Schedule II | legal_de = Anlage II | CAS_number = 1971007-92-7 | PubChem = 119025022 | ChemSpiderID = 52085000 | UNII = 7J1X0F7F3V | C=20 | H=28 | F=1 | N=3 | O=3 | smiles = CC(C)(C)C(C(=O)OC)NC(=O)c1cn(CCCCC(F)F)c2c1cccc2 | StdInChI = 1S/C20H28FN3O3/c1-20(2,3)17(19(26)27-4)23-18(25)16-14-12-10-9-11-13(14)15(22-16)7-5-6-8-21/h9-12,17H,5-8H2,1-4H3,(H,22,23,25) | StdInChIKey = QWZQXKZQXQXQXQ-UHFFFAOYSA-N }}
5F-MDMB-PICA is a synthetic cannabinoid that has been used as an active ingredient in synthetic cannabis products. It is a potent agonist of the CB1 receptor and has been associated with numerous cases of severe toxicity and fatalities.
Chemical Structure and Properties[edit]
5F-MDMB-PICA is chemically classified as an indazole-based synthetic cannabinoid. Its IUPAC name is Methyl 2-[[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino]-3,3-dimethylbutanoate. The compound has a molecular formula of C20H28FN3O3 and a molecular weight of 377.46 g/mol.
Pharmacology[edit]
5F-MDMB-PICA acts as a potent agonist at the CB1 receptor, which is primarily responsible for the psychoactive effects of cannabinoids. The compound has a high binding affinity for the CB1 receptor, leading to strong psychoactive effects. It has been reported to cause severe adverse effects, including seizures, tachycardia, and acute kidney injury.
Legal Status[edit]
5F-MDMB-PICA is classified as a Schedule I controlled substance in the United States, indicating that it is considered to have a high potential for abuse and no accepted medical use. In the United Kingdom, it is classified as a Class B drug under the Misuse of Drugs Act 1971. It is also controlled under various international regulations.
Health Risks[edit]
The use of 5F-MDMB-PICA has been associated with numerous health risks. These include severe toxicity, psychosis, and death. The compound has been linked to multiple cases of overdose and has been found in various forensic toxicology reports.
Related Compounds[edit]
5F-MDMB-PICA is structurally related to other synthetic cannabinoids such as 5F-ADB, MDMB-CHMICA, and AB-FUBINACA. These compounds share similar pharmacological profiles and have been associated with similar adverse effects.
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian